
Ask a doctor about a prescription for NESYRGY 5 MG/5 MG FILM-COATED TABLETS
Package Leaflet: Information for the Patient
Nesyrgy 5 mg / 5 mg Film-Coated Tablets
nebivolol/amlodipine
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the Package Leaflet
Nesyrgy contains two active substances called nebivolol and amlodipine. These two substances help control high blood pressure:
Nesyrgy is used to treat high blood pressure in adult patients who are already taking nebivolol and amlodipine in separate tablets at the same doses.
Do not take Nesyrgy if:
Do not take this medicine if any of the above applies to you. If you are not sure, talk to your doctor before taking this medicine.
Warnings and precautions
Talk to your doctor or pharmacist before starting to take this medicine.
Tell your doctor if:
As with any other medicine that lowers blood pressure, an excessive decrease in blood pressure in patients with disorders of blood flow to the heart or brain may cause a heart attack or stroke. Therefore, your doctor will carefully monitor your blood pressure.
See also the information under the heading 'Do not take Nesyrgy'.
Children and adolescents
Due to the lack of data on the use of this medicine in children and adolescents under 18 years of age, the use of Nesyrgyis not recommended in them.
Other medicines and Nesyrgy
Tell your doctor if you are taking, have recently taken, or might take any other medicines.
In particular, tell your doctor if you are taking:
Taking Nesyrgy with food and drinks
Nesyrgy can be taken with or without food.
People taking this medicine should not consume grapefruit juice or grapefruit. This is because grapefruit and grapefruit juice can lead to an increase in blood levels of the active substance amlodipine, which can cause an unpredictable increase in the blood pressure-lowering effect of this medicine.
Be careful when drinking alcohol while taking this medicine, as you may feel dizzy or faint. If this happens, do not drink alcohol, including wine, beer, or soft drinks that contain alcohol.
Pregnancy and breast-feeding
Pregnancy
As there are no sufficient clinical data available related to pregnant women, this medicine is not recommended during pregnancy. This medicine may only be considered if there is no safer alternative and after your doctor has performed a careful individual benefit/risk assessment, so if you are pregnant, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine. Do not forget to consult your doctor before taking this medicine.
In case of use during pregnancy, careful monitoring of the fetus and newborn may be necessary.
Breast-feeding
If you are breast-feeding or plan to start breast-feeding, consult your doctor before using this medicine. This medicine is not recommended in breast-feeding mothers, and your doctor may choose another medicine for you if you wish to breast-feed.
Driving and using machines
This medicine may affect your ability to drive or use machines. If the medicine makes you feel unwell, dizzy, or tired, or gives you a headache, do not drive or use machines and contact your doctor immediately.
This medicine contains less than 1 mmol of sodium (23 mg) per film-coated tablet, which is essentially "sodium-free".
Follow exactly the administration instructions of this medicine given by your doctor. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is one tablet per day, preferably at the same time each day.
Nesyrgy can be taken before, during, or after meals, but, alternatively, it can be taken independently of meals. The tablet is best taken with water, without chewing. Do not take Nesyrgy with grapefruit juice.
The score line is only for breaking the tablet if you have difficulty swallowing the whole tablet.
If you take more Nesyrgy than you should
If you accidentally take an overdose of this medicine, inform your doctor or pharmacist immediately.
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount taken.
The most frequent symptoms and signs of overdose are low blood pressure with fainting (hypotension) with possible increased heart rate (reflex tachycardia), very slow heart rate (bradycardia), asthma-like shortness of breath (bronchospasm), and acute heart failure.
Excess fluid may accumulate in your lungs (pulmonary edema) causing difficulty breathing, which can develop up to 24-48 hours after ingestion.
If you forget to take Nesyrgy
If you forget to take this medicine, but remember soon after when you should have taken it, take the daily dose as you usually do. However, if a long time has passed (e.g., several hours), so that it is close to the next dose, skip the missed dose and take the next scheduled dose at the usual time. Do not take a double dose to make up for missed doses. However, repeated forgetting should be avoided.
If you stop taking Nesyrgy
Always consult your doctor before stopping treatment with this medicine.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Consult your doctor immediately if you experience any of the following adverse effects after taking this medicine.
Other adverse effects that have been reported are presented below. If any of them cause you problems, consult your doctor.
Other possible adverse effects withNesyrgy:
Very common adverse effects(may affect more than 1 in 10 people):
Common adverse effects(may affect up to 1 in 10 people):
Uncommon adverse effects(may affect up to 1 in 100 people):
Rare adverse effects(may affect up to 1 in 1,000 people):
Very rare adverse effects(may affect up to 1 in 10,000 people):
Frequency not known(frequency cannot be estimated from the available data):
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the box and on the blister after CAD. The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Medicines should not be thrown away through the drains or into the trash. Deposit the containers and medicines that you no longer need in the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the containers and medicines that you no longer need. In this way, you will help protect the environment.
Composition of Nesyrgy
Each film-coated tablet contains 5 mg of nebivolol (as nebivolol hydrochloride: 2.5 mg of d-nebivolol and 2.5 mg of l-nebivolol) and 5 mg of amlodipine (as amlodipine besylate).
Core of the tablet:microcrystalline cellulose, sodium croscarmellose, corn starch, hypromellose, polysorbate 80, colloidal anhydrous silica, magnesium stearate.
Film coating:OPADRY®02B220019 yellow (composed of: hypromellose, titanium dioxide, macrogol 400, yellow iron oxide (E172)).
Appearance of the Product and Package Contents
Nesyrgy 5 mg/5 mg film-coated tablets are yellow, oval.
Nesyrgy is available in PVC/PVDC-Al or OPA/Al/PVC-Al blisters, abbreviated as Al-Al blisters, in packages containing 14, 28, 30, 56, 84, 90 film-coated tablets.
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Menarini International Operations Luxembourg S.A.
1, Avenue de la Gare, L-1611 Luxembourg, Luxembourg
Manufacturer
Saneca Pharmaceuticals, a.s.
Nitrianska 100, 920 27 Hlohovec, Slovakia
Local Representative
Laboratorios Menarini, S.A.
Alfons XII, 587 – 08918 Badalona (Barcelona), Spain
This medicine is authorized in the Member States of the European Economic Area with the following names:
Belgium, Bulgaria, Cyprus, Croatia, Estonia, Slovenia, Spain, France, Greece, Hungary, Italy, Latvia, Luxembourg, Poland, Czech Republic, Slovakia, Romania: Nesyrgy
Austria, Ireland, Portugal: Nebkliq
Lithuania: Kliqqo
Date of the last revision of this prospectus: April 2025
Other Sources of Information
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS http://www.aemps.gob.es/)
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for NESYRGY 5 MG/5 MG FILM-COATED TABLETS – subject to medical assessment and local rules.